525O A phase I dose escalation study of PRS-343, a...

Annals of Oncology 2020 / 09 Vol. 31

525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies

Ku, G., Bendell, J.C., Tolcher, A.W., Hurvitz, S.A., Krishnamurthy, A., El-Khoueiry, A.B., Patnaik, A., Shroff, R.T., Noonan, A., Hahn, N.M., Matrana, M., Zettl, M., Aviano, K., Mar, L., Jolicoeur, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.639
Date:
September, 2020
File:
PDF, 185 KB
2020
Conversion to is in progress
Conversion to is failed